PRELUDE THERAPEUTICS INCORPORATED - COMMON STOCK

Jane Huang, M.D., Joins Prelude Therapeutics as President and Chief Medical Officer

09 3 2022 07:00:01 提供 Nasdaq GlobeNewswire

Prelude Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

11 2 2022 06:00:00 提供 Nasdaq GlobeNewswire

Prelude Therapeutics to Present at the H.C. Wainwright BioConnect Virtual Conference

04 1 2022 06:00:02 提供 Nasdaq GlobeNewswire

Prelude Therapeutics to Participate at the 4th Annual Evercore ISI HealthCONx Conference

23 11 2021 06:00:00 提供 Nasdaq GlobeNewswire

Prelude Therapeutics Announces Third Quarter 2021 Financial Results and Operations Update

12 11 2021 07:00:01 提供 Nasdaq GlobeNewswire

Prelude Therapeutics Announces IND Clearance for PRT2527, a Highly Selective CDK9 Inhibitor

08 11 2021 08:00:01 提供 Nasdaq GlobeNewswire

Prelude Therapeutics Announces Presentation of Encouraging Data from Multiple Programs at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

07 10 2021 08:00:01 提供 Nasdaq GlobeNewswire

Prelude Therapeutics Announces Participation at Two Upcoming Virtual Investor Conferences

02 9 2021 06:00:02 提供 Nasdaq GlobeNewswire

Prelude Therapeutics Announces Second Quarter 2021 Financial Results and Operations Update

12 8 2021 06:30:00 提供 Nasdaq GlobeNewswire

Prelude Therapeutics Announces Appointment of Martin Babler to its Board of Directors

19 7 2021 06:00:01 提供 Nasdaq GlobeNewswire

Prelude Therapeutics Announces Participation at Two Upcoming Virtual Investor Conferences

02 6 2021 06:00:00 提供 Nasdaq GlobeNewswire

Prelude Therapeutics Announces First Quarter 2021 Financial Results and Operations Update

11 5 2021 06:30:00 提供 Nasdaq GlobeNewswire

Prelude Therapeutics Announces Presentation at BofA Securities 2021 Virtual Health Care Conference

05 5 2021 06:00:01 提供 Nasdaq GlobeNewswire

Prelude Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Operational Update

16 3 2021 07:00:02 提供 Nasdaq GlobeNewswire

Prelude Therapeutics Announces Participation at Three Upcoming Virtual Investor Conferences

03 3 2021 06:00:00 提供 Nasdaq GlobeNewswire

Prelude Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

11 1 2021 17:20:00 提供 Nasdaq GlobeNewswire

Prelude Therapeutics Announces Pricing of Upsized Public Offering

06 1 2021 23:12:43 提供 Nasdaq GlobeNewswire

Prelude Therapeutics Announces Launch of Proposed Public Offering

04 1 2021 15:16:38 提供 Nasdaq GlobeNewswire